A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies

NCT07011186 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Myeloid Malignancy

Interventions

DRUG: TQB3909 Tablets + Azacitidine

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.